How to buy Pacific Edge (PEB) shares
Learn how to easily invest in Pacific Edge shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Pacific Edge is a diagnostics & research business based in Australia. Pacific Edge shares (PEB) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Pacific Edge has a trailing 12-month revenue of around $11.5 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Pacific Edge
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Pacific Edge. Find the share by name or ticker symbol: PEB. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Pacific Edge reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check on your investment. Congratulations, you own a part of Pacific Edge. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
Pacific Edge stock price (ASX:PEB)Use our graph to track the performance of PEB stocks over time.
Pacific Edge shares at a glance
|52-week range||$0.72 - $1.605|
|50-day moving average||$0.817|
|200-day moving average||$1.0976|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.02|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Pacific Edge stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Pacific Edge price performance over time
|1 week (2022-06-29)||3.23%|
|1 month (2022-06-07)||-3.03%|
|3 months (2022-04-06)||-31.18%|
|6 months (2022-01-06)||-48.18%|
Pacific Edge financials
|Revenue TTM||$11.5 million|
|Gross profit TTM||$3.5 million|
|Return on assets TTM||-16.16%|
|Return on equity TTM||-26.02%|
|Market capitalisation||$599 million|
TTM: trailing 12 months
Pacific Edge share dividends
We're not expecting Pacific Edge to pay a dividend over the next 12 months.
Pacific Edge share price volatility
Over the last 12 months, Pacific Edge's shares have ranged in value from as little as $0.72 up to $1.605. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Pacific Edge's is 0.8049. This would suggest that Pacific Edge's shares are less volatile than average (for this exchange).
Pacific Edge overview
Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, Singapore, and internationally. It operates in two segments, Commercial and Research. The company offers Cxbladder, a genomic urine tests for the detection and management of bladder cancer. It is also developing Cxbladder Resolve, a product designed to identify high grade or late stage bladder cancer and provide increased clinical resolution; Cxbladder Triage, a product that analyses the gene expression of urine-based biomarkers alongside information on known bladder cancer risk factors like age, gender, and smoking history to rule out patients with a low risk of having the disease; Cxbladder Detect that can be used as an adjunct to cystoscopy or as a substitute for other urine-based tests or imaging procedures; and Cxbladder Monitor, which is a non-invasive and easy-to-use test to rule out the return of bladder cancer. In addition, the company is developing Cxcolorectal (prognosis Gen II), a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancers; and products for bladder, gastric, colorectal, endometrial cancers, and melanoma. The company was incorporated in 2001 and is headquartered in Dunedin, New Zealand.
Stocks similar to Pacific Edge
Pacific Edge in the news
Frequently asked questions
More guides on Finder
How to buy Nordic Nickel (NNL) shares
Steps to owning and managing Nordic Nickel shares.
How to buy Dusk (DSK) shares
Steps to owning and managing Dusk shares.
How to invest in the Octava Minerals IPO
Everything we know about the Octava Minerals IPO, plus information on how to buy in.
How to invest in the Australia Sunny Glass Group IPO
Everything we know about the Australia Sunny Glass Group IPO, plus information on how to buy in.
How to buy Kincora Copper (KCC) shares
Steps to owning and managing Kincora Copper shares.
How to invest in the Dragon Mountain Gold IPO
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
How to buy Arcadia Minerals (AM7) shares
Steps to owning and managing Arcadia Minerals shares.
How to buy Nexgen Energy (NXG) shares
Steps to owning and managing Nexgen Energy shares.
How to buy Keypath Education (KED) shares
Steps to owning and managing Keypath Education shares.
What are green bonds and how do they impact the world?
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
Ask an Expert